• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

fiona.hegijohnson@unimelb.edu.au

Credentials


Position
Honorary Conjoint Principal Fellow
The Sir Peter MacCallum Department of Oncology
ORCID

0000-0002-4543-8802

Dr Fiona Hegi-Johnson

Honorary Conjoint Principal Fellow
The Sir Peter MacCallum Department of Oncology

60 Scholarly works
0 Projects

HIGHLIGHTS

  • 2026

    Journal article

    A Response to the Letter to the Editor
    DOI: 10.1016/j.jtho.2026.103728
  • 2026

    Journal article

    Updates in Small Cell Lung Cancer Treatment: No Longer Too Small to Ignore-A Review of Recent Therapeutic Advances.
    DOI: 10.1200/EDBK-26-524964
  • 2026

    Journal article

    Osimertinib and Stereotactic Radiosurgery for Brain Metastases in EGFR-Mutated Lung Cancer: The STARLET Joint Analysis of OUTRUN and LUOSICNS Randomized Trials
    DOI: 10.1016/j.jtho.2026.01.001
  • 2025

    Journal article

    50 Years of Progress in NSCLC: A New Fellow’s Guide in the Clinic
    DOI: 10.1016/j.jtho.2025.06.028
  • 2025

    Journal article

    EP.13.37 Immunotherapy Plus Chemoradiotherapy for Limited-Stage Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Trials
    DOI: 10.1016/j.jtho.2025.09.1632
  • 2025

    Conference Proceedings

    Higher Baseline Monocyte and Neutrophil Counts Are Associated with Significantly Worse Overall Survival in NSCLC Patients Treated with Curative-Intent Chemoradiation
    DOI: 10.1016/j.ijrobp.2025.06.3671
  • 2025

    Journal article

    Efficacy and Safety of Four Weeks of Moderately Hypofractionated Chemoradiation for Unresectable, Stage 3 Non–Small Cell Lung Cancer: A Systematic Review
    DOI: 10.1111/ajco.14152
Fiona Hegi-Johnson

RECENT SCHOLARLY WORKS

  • 2025

    Journal article

    Completion Rates for Patients Undergoing Concurrent Chemoradiotherapy for Stage III Nonsmall Cell Lung Cancer and its Importance in the Era of Consolidation Immunotherapy: A Cohort Study
    DOI: 10.1016/j.cllc.2025.02.010
  • 2025

    Journal article

    Corrigendum to ‘OA09.04 Osimertinib with or without SRS for Brain Metastases from EGFRm NSCLC: Pooled Analysis of Two RCTs’ [Journal of Thoracic Oncology Vol. 19 No. 10S (2024) S28] (Journal of Thoracic Oncology (2024) 19(10S) (S28–S29), (S1556086424009286), (10.1016/j.jtho.2024.09.054))
    DOI: 10.1016/j.jtho.2025.02.016
  • 2025

    Journal article

    In Reply to Luh
    DOI: 10.1016/j.ijrobp.2024.11.110

Acknowledgement of Country

We acknowledge Aboriginal and Torres Strait Islander people as the Traditional Owners of the unceded lands on which we work, learn and live. We pay respect to Elders past, present and future, and acknowledge the importance of Indigenous knowledge in the Academy.

Read about our Indigenous priorities

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Campus locations  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia

facebookIconlinkedinIconinstagramIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy

CRICOS number: 00116K     ABN: 84 002 705 224